|
|
Article: Respiratory Syncytial Virus "Respiratory Syncytial Virus Immune Globulin for Prophylaxis Against Respiratory Syncytial Virus Disease in Infants and Children with Congenital Heart Disease." Journal of Pediatrics, October 1998;133(4):492-499.
- Article from:
- Immunotherapy Weekly
- Article date:
- December 7, 1998
CopyrightCOPYRIGHT 1998 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Simoes, E.A.F.; Sondheimer, H.M.; Top, F.H.; Meissner, H.C.; Welliver, R.C.; Kramer, A.A.; Groothuis, J.R. According to the authors' abstract of an article published in Journal of Pediatrics, "OBJECTIVE: To examine the effectiveness of respiratory syncytial virus immune globulin administered intravenously (RSV-IGIV) in reducing hospitalization for treatment of RSV in children with congenital heart disease (CHD). METHODS: Children younger than 4 years of age were randomly assigned to a treatment group receiving RSV-IGIV, 750 mg/kg, monthly or to a control group not receiving infusions. Surveillance for respiratory tract infections was carried out and management ...